Update on bipolar disorder biomarker candidates
- PMID: 27737600
- DOI: 10.1080/14737159.2016.1248413
Update on bipolar disorder biomarker candidates
Abstract
Bipolar disorder is a chronic and disabling mood disorder with a complex pathophysiological basis. A significant percentage of patients do not receive correct diagnosis which directly influences therapeutic response, rendering recovery troublesome. There is a long-standing need for proper non-clinically based tools for diagnosis, treatment selection and follow-up of such patients. Areas covered: In the past decade, the scientific community has shown a great interest in biomarker development. Here, we highlight the different potential biomarkers and we discuss their feasibility and their possible clinical relevance. Expert commentary: To date, despite the major ongoing trials and consortia with promising future perspectives, no reliable biomarker of bipolar disorder has been fully defined.
Keywords: Bipolar disorder; biomarkers; genomic analysis; neuroimaging; peripheral markers.
Comment in
-
Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis?Expert Rev Mol Diagn. 2017 Feb;17(2):105-106. doi: 10.1080/14737159.2017.1270757. Epub 2016 Dec 16. Expert Rev Mol Diagn. 2017. PMID: 27935329 No abstract available.
-
Convergent lines of evidence support the role of uric acid levels as a potential biomarker in bipolar disorder.Expert Rev Mol Diagn. 2017 Feb;17(2):107-108. doi: 10.1080/14737159.2017.1270758. Epub 2016 Dec 20. Expert Rev Mol Diagn. 2017. PMID: 27935358 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous